Depreciation of Protagenic Therapeutics, Inc.\new from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Protagenic Therapeutics, Inc.\new quarterly and annual Depreciation in USD history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • Protagenic Therapeutics, Inc.\new Depreciation for the quarter ending 31 Dec 2025 was $12,572.
  • Protagenic Therapeutics, Inc.\new Depreciation for the twelve months ending 31 Dec 2025 was $50,287, a 100% increase year-over-year.
  • Protagenic Therapeutics, Inc.\new annual Depreciation for 2024 was $50,286, a 78% increase from 2023.
  • Protagenic Therapeutics, Inc.\new annual Depreciation for 2023 was $28,218, a 93960% increase from 2022.
  • Protagenic Therapeutics, Inc.\new annual Depreciation for 2022 was $30.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Protagenic Therapeutics, Inc.\new Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $50,287 $12,572 +$12,572 01 Oct 2025 31 Dec 2025 10-Q 09 Mar 2026 2026 Q3
Q3 2025 $37,715 $12,572 +$12,572 01 Jul 2025 30 Sep 2025 10-Q 26 Nov 2025 2026 Q2
Q2 2025 $25,143 $12,571 $0 0% 01 Apr 2025 30 Jun 2025 10-QT 10 Sep 2025 2026 Q1
Q1 2025 $25,143 $12,572 $0 0% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $25,143 $0 -$26,618 -100% 01 Oct 2024 31 Dec 2024 10-Q 09 Mar 2026 2026 Q3
Q3 2024 $51,761 $0 -$1,419 -100% 01 Jul 2024 30 Sep 2024 10-Q 26 Nov 2025 2026 Q2
Q2 2024 $53,180 $12,571 +$12,480 +13714% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $40,700 $12,572 +$12,482 +13869% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 $28,218 $26,618 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $1,419 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $91 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 $90 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q1 2020 $84 -$1 -1.2% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q1 2019 $85 -$4 -4.5% 01 Jan 2019 31 Mar 2019 10-Q 18 Jun 2020 2020 Q1
Q1 2018 $89 -$828 -90% 01 Jan 2018 31 Mar 2018 10-Q 16 May 2019 2019 Q1
Q1 2017 $917 +$835 +1018% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q1 2016 $82 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1

Protagenic Therapeutics, Inc.\new Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $50,286 +$22,068 +78% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $28,218 +$28,188 +93960% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $30 01 Jan 2022 31 Dec 2022 10-K/A 14 May 2024 2023 FY
2020 $286 -$53 -16% 01 Jan 2020 31 Dec 2020 10-K 07 Apr 2022 2021 FY
2019 $339 -$8 -2.3% 01 Jan 2019 31 Dec 2019 10-K 25 Mar 2021 2020 FY
2018 $347 +$199 +134% 01 Jan 2018 31 Dec 2018 10-K 29 Apr 2020 2019 FY
2017 $148 -$386 -72% 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2019 2018 FY
2016 $534 +$391 +273% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2018 2017 FY
2015 $143 -$237 -62% 01 Jan 2015 31 Dec 2015 10-K/A 08 May 2017 2016 FY
2014 $380 01 Jan 2014 31 Dec 2014 8-K/A 12 Jul 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.